Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

1,702 public trials 177 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Epigenetic Reprogramming in Relapse/Refractory AML

NCT03263936

Conditions
Acute Myelogenous Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Orange County Orange, California, United States
  • UCSF School of Medicine San Francisco, California, United States
  • The Children's Hospital, University of Colorado Aurora, Colorado, United States
View all 33 locations
View Trial Details
Completed

Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children

NCT02512926

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Stanford University School of Medicine and Stanford Cancer Institute Palo Alto, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

A Phase 1 Study of WU-NK-101 in Patients With Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)

NCT05470140

Conditions
Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Healthcare Palo Alto, California, United States
  • Norton Health Care Louisville, Kentucky, United States
  • University of Maryland Baltimore, Maryland, United States
View Trial Details
Completed

A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

NCT03069352

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • H. Lee Moffit Cancer Center /ID# 164273 Tampa, Florida, United States
  • Norton Cancer Institute /ID# 158998 Louisville, Kentucky, United States
  • Univ of Pittsburgh Med Ctr /ID# 158997 Pittsburgh, Pennsylvania, United States
  • Univ TX, MD Anderson /ID# 159678 Houston, Texas, United States
View all 109 locations
View Trial Details
Completed

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib

NCT00777036

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +2 more
Locations
  • Local Institution Birmingham, Alabama, United States
  • Local Institution - 0005 Phoenix, Arizona, United States
  • Phoenix Children'S Hospital Phoenix, Arizona, United States
  • Jonathan Jaques Children'S Cancer Center Long Beach, California, United States
View all 174 locations
View Trial Details
Completed

Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)

NCT02269280

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • NYP/Weill Cornell Medical Center New York, United States
View Trial Details

Related conditions